Collaboration project for better health is progressing strongly

Last spring, Rarity was awarded a grant from Swelife and Medtech4Health. The idea is to study superRCA for precision diagnostics and relapse detection for Acute Myeloid Leukemia and Myelodysplastic syndrome – ultimately improving treatment outcome, reducing patient burden and cost. Part of the project aims to benchmark superRCA against ddPCR and investigate to what extent […]